Tax

State & Local Tax (Current)

Vertex Pharmaceuticals State & Local Tax (Current) remained flat by 0.0% to $8.98M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 69.6%, from $29.55M to $8.98M. Over 2 years (FY 2023 to FY 2025), State & Local Tax (Current) shows a downward trend with a -11.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionTax
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

An increase may reflect expansion into higher-tax jurisdictions or changes in state-level tax policies.

Detailed definition

The portion of the total income tax provision that is currently payable to state and local government jurisdictions. Thi...

Peer comparison

Standard component of the total tax provision for companies with multi-state operations.

Metric ID: is_msft_current_state_and_local_tax_expense

Historical Data

3 years
 FY'23FY'24FY'25
Value$46.20M$118.20M$35.90M
YoY Change—+155.8%-69.6%
Range$35.90M – $118.20M
CAGR-11.8%
Avg YoY Growth+43.1%
Median YoY Growth+43.1%

Frequently Asked Questions

What is Vertex Pharmaceuticals's state & local tax (current)?
Vertex Pharmaceuticals (VRTX) reported state & local tax (current) of $8.98M in Q4 2025.
How has Vertex Pharmaceuticals's state & local tax (current) changed year-over-year?
Vertex Pharmaceuticals's state & local tax (current) decreased by 69.6% year-over-year, from $29.55M to $8.98M.
What is the long-term trend for Vertex Pharmaceuticals's state & local tax (current)?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's state & local tax (current) has grown at a -11.8% compound annual growth rate (CAGR), from $46.20M to $35.90M.
What does state & local tax (current) mean?
The amount of income tax currently owed to state and local governments for the period.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.